Background illustration for clinical trials search

Paid Clinical Trials Syracuse

Discover 256 paid clinical trials in Syracuse, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Web-based CBT for Recent Veterans Experiencing Problems With Trauma Symptoms or Alcohol/Drug Use

for
Post-Traumatic Stress Symptoms,
Location: Syracuse NY, Buffalo NY
Sponsor: National Development and Research Institutes, Inc.

Sex: All

Age: 18+

Code: NCT01710943

Phase 1, Phase 2, Recruiting

Manual Therapy in Addition to Pulmonary Rehabilitation in Moderate Chronic Obstructive Pulmonary Disease.

for
Chronic Obstructive Pulmonary Disease Moderate
Location: Syracuse NY
Sponsor: Canandaigua VA Medical Center

Sex: All

Age: 50 - 70

Code: NCT04386590

Phase 2, Phase 3, Recruiting

Stimulation for Bowel Emptying

for
Neurogenic Bowel Dysfunction
Location: Syracuse NY
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT06078176

Recruiting

Testing an Adaptive Intervention for Peer-Supported Mobile Health for Primary Care Veterans With Psychological Distress

for
Psychological Distress
Location: Syracuse NY
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT07507747

Recruiting

Leg Stretching Using an Exoskeleton on Demand for People With Spasticity

for
Spasticity, Movement Disorders, Spinal Cord Injury
Location: Syracuse NY
Sponsor: VA Office of Research and Development

Sex: All

Age: 18+

Code: NCT05926596

Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

for
Non-muscle Invasive Bladder Cancer
Location: Syracuse NY, Rochester NY, Toronto, The Bronx NY,
Sponsor: Protara Therapeutics

Sex: All

Age: 18+

Code: NCT05951179

Phase 2, Recruiting

Study of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate Cancer

for
Metastatic Prostate Cancer
Location: Syracuse NY, Long Island City NY, New Haven CT,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT06800313

Phase 1, Phase 2, Recruiting

An Open-label Study Comparing Lutetium (177Lu) Vipivotide Tetraxetan Versus Observation in PSMA Positive OMPC.

for
Oligometastatic Prostate Cancer (OMPC)
Location: Syracuse NY, Ottawa, Toronto, The Bronx NY, New York NY,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT05939414

Phase 3, Recruiting

Intravesical Photodynamic Therapy ("PDT") in BCG-Unresponsive/Intolerant Non-Muscle Invasive Bladder Cancer ("NMIBC") Patients

for
Non-Muscle Invasive Bladder Cancer ("NMIBC") Unresponsive/Intolerant to BCG,
Location: Syracuse NY, Toronto, Hamilton, Montreal, London,
Sponsor: Theralase® Technologies Inc.

Sex: All

Age: 18+

Code: NCT03945162

Phase 2, Recruiting

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

for
Superficial Bladder Cancer,
Location: Syracuse NY, Albany NY, Buffalo NY, Toronto,
Sponsor: enGene, Inc.

Sex: All

Age: 18+

Code: NCT04752722

Phase 1, Phase 2, Recruiting

A Study of JNJ-101556143 in Participants With Metastatic Prostate Cancer

for
Prostatic Neoplasms
Location: Syracuse NY, Plymouth MA, Carmel IN, Chicago Ridge IL,
Sponsor: Janssen Research & Development, LLC

Sex: Male

Age: 18+

Code: NCT07832292

Phase 2, Recruiting

Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial Carcinoma

for
Low Grade Upper Tract Urothelial Carcinoma
Location: Syracuse NY, Albany NY, Radnor PA, Sewell NJ,
Sponsor: Tyra Biosciences, Inc

Sex: All

Age: 18+

Code: NCT07265947

Phase 2, Recruiting

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

for
Prostate Cancer
Location: Syracuse NY, Cooperstown NY, Rochester NY, The Bronx NY,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06855277

Phase 3, Recruiting

A Study to Evaluate TAR-210 Versus Intravesical Chemotherapy Treatment in Participants With High Risk Non-Muscle-Invasive Bladder Cancer

for
Non-Muscle Invasive Bladder Neoplasms
Location: Syracuse NY, Lancaster PA, Bala-Cynwyd PA,
Sponsor: Janssen Research & Development, LLC

Sex: All

Age: 18+

Code: NCT06919965

Phase 3, Recruiting

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

for
Prostate Cancer
Location: Syracuse NY, The Bronx NY, New York NY, Hartford CT,
Sponsor: Novartis Pharmaceuticals

Sex: Male

Age: 18 - 70+

Code: NCT06780670

Phase 2, Phase 3, Recruiting

Metastatic Castrate-Resistant Prostate Cancer Subjects Treated With PROVENGE® + One Infusion of Sipuleucel-T

for
Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Location: Syracuse NY, North Hills NY, Lancaster PA,
Sponsor: Dendreon

Sex: Male

Age: 18+

Code: NCT06134232

Phase 2, Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

for
Metastatic Castration-resistant Prostate Cancer (mCRPC),
Location: Syracuse NY, Ottawa, Toronto, Mississauga,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT06136650

Phase 3, Recruiting

AI-Assisted Treatment for Residual Speech Sound Disorders

for
Speech Sound Disorder
Location: Syracuse NY
Sponsor: Syracuse University

Sex: All

Age: 9 - 17

Code: NCT05988515

Recruiting

Intensive Speech Motor Chaining Treatment for Residual Speech Sound Disorders

for
Speech Sound Disorder
Location: Syracuse NY
Sponsor: Syracuse University

Sex: All

Age: 9 - 17

Code: NCT05929859

Phase 1, Phase 2, Recruiting

Acceptance and Commitment Therapy for HIV+ Hazardous Drinkers

for
HIV-1-infection, Alcohol Drinking
Location: Syracuse NY
Sponsor: Syracuse University

Sex: All

Age: 18+

Code: NCT06648629

Recruiting